AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
INDUCTION OF TIRILAZAD CLEARANCE BY PHENYTOIN
Authors: FLEISHAKER JC PEARSON LK PETERS GR
Citation: Jc. Fleishaker et al., INDUCTION OF TIRILAZAD CLEARANCE BY PHENYTOIN, Biopharmaceutics & drug disposition, 19(2), 1998, pp. 91-96
TOLERABILITY AND SAFETY OF HIGH-DOSE REMACEMIDE HYDROCHLORIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY
Authors: PRIVITERA MD FRENCH JA MCCARTHY MB ALDERFER VB PETERS GR MEANS ED
Citation: Md. Privitera et al., TOLERABILITY AND SAFETY OF HIGH-DOSE REMACEMIDE HYDROCHLORIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY, Neurology, 50(4), 1998, pp. 64002-64002
BIOTRANSFORMATION OF TIRILAZAD IN HUMAN - 4 - EFFECT OF FINASTERIDE ON TIRILAZAD CLEARANCE AND REDUCED METABOLITE FORMATION
Authors: FLEISHAKER JC PEARSON PG WIENKERS LC PEARSON LK MOORE TA PETERS GR
Citation: Jc. Fleishaker et al., BIOTRANSFORMATION OF TIRILAZAD IN HUMAN - 4 - EFFECT OF FINASTERIDE ON TIRILAZAD CLEARANCE AND REDUCED METABOLITE FORMATION, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 591-597
PHARMACOKINETICS OF TIRILAZAD IN HEALTHY MALE-SUBJECTS AT DOSES ABOVE6 MG KG/DAY/
Authors: FLEISHAKER JC PETERS GR
Citation: Jc. Fleishaker et Gr. Peters, PHARMACOKINETICS OF TIRILAZAD IN HEALTHY MALE-SUBJECTS AT DOSES ABOVE6 MG KG/DAY/, International journal of clinical pharmacology and therapeutics, 35(1), 1997, pp. 28-32
PALEO-INDIAN OCCUPATIONS IN NORTHEASTERN MINNESOTA - HOW EARLY (QUARTERNARY STUDIES, GEOLOGY, ARCHAEOLOGY)
Authors: MULHOLLAND SC MULHOLLAND SL PETERS GR HUBER JK MOOERS HD
Citation: Sc. Mulholland et al., PALEO-INDIAN OCCUPATIONS IN NORTHEASTERN MINNESOTA - HOW EARLY (QUARTERNARY STUDIES, GEOLOGY, ARCHAEOLOGY), North American archaeologist, 18(4), 1997, pp. 371-400
STEADY-STATE PHARMACOKINETIC PROPERTIES OF PRAMIPEXOLE IN HEALTHY-VOLUNTEERS
Authors: WRIGHT CE SISSON TL ICHHPURANI AK PETERS GR
Citation: Ce. Wright et al., STEADY-STATE PHARMACOKINETIC PROPERTIES OF PRAMIPEXOLE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(6), 1997, pp. 520-525
PRAMIPEXOLE AND LEVODOPA PHARMACOKINETICS FOLLOWING CONCOMITANT ADMINISTRATION
Authors: WRIGHT CE SISSON TL ICHHPURANI AK PETERS GR
Citation: Ce. Wright et al., PRAMIPEXOLE AND LEVODOPA PHARMACOKINETICS FOLLOWING CONCOMITANT ADMINISTRATION, Neurology, 48(3), 1997, pp. 3104-3104
DOES FEVER WORSEN FUNCTIONAL OUTCOME AFTER ACUTE ISCHEMIC STROKE
Authors: HWANG LJ PETERS GR BURKETT BJ TRUSKOWSKI L
Citation: Lj. Hwang et al., DOES FEVER WORSEN FUNCTIONAL OUTCOME AFTER ACUTE ISCHEMIC STROKE, Neurology, 48(3), 1997, pp. 5018-5018
FINASTERIDE INHIBITS FORMATION OF REDUCED ACTIVE METABOLITES OF TIRILAZAD
Authors: FLEISHAKER JC PEARSON LK PEARSON PG WIENKERS LC MOORE TA PETERS GR
Citation: Jc. Fleishaker et al., FINASTERIDE INHIBITS FORMATION OF REDUCED ACTIVE METABOLITES OF TIRILAZAD, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 78-78
ENVIRONMENTAL ASPECTS OF ARSENIC TOXICITY
Authors: PETERS GR MCCURDY RF HINDMARSH JT
Citation: Gr. Peters et al., ENVIRONMENTAL ASPECTS OF ARSENIC TOXICITY, Critical reviews in clinical laboratory sciences, 33(6), 1996, pp. 457-493
AN EVALUATION OF SOME CARDIOVASCULAR EFFECTS OF PRAMIPEXOLE IN HEALTHY-VOLUNTEERS AND THEIR ANTAGONISM BY DOMPERIDONE
Authors: DONALDSON KM BLOOD P PETERS GR WRIGHT CE HARRY JD
Citation: Km. Donaldson et al., AN EVALUATION OF SOME CARDIOVASCULAR EFFECTS OF PRAMIPEXOLE IN HEALTHY-VOLUNTEERS AND THEIR ANTAGONISM BY DOMPERIDONE, British journal of clinical pharmacology, 42(5), 1996, pp. 660-661
PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTSRECEIVING A LOADING REGIMEN AND MAINTENANCE REGIMEN OF 10 MG KG/DAY OF TIRILAZAD/
Authors: FLEISHAKER JC PETERS GR
Citation: Jc. Fleishaker et Gr. Peters, PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTSRECEIVING A LOADING REGIMEN AND MAINTENANCE REGIMEN OF 10 MG KG/DAY OF TIRILAZAD/, Journal of clinical pharmacology, 36(9), 1996, pp. 809-813
A RANDOMIZED TRIAL OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE STROKE (RANTTAS)
Authors: SCOTT P BARSAN W FREDERIKSEN S KRONICK S ZINK BJ DOMEIER RM MITCHINER JC JUDGE FP LEVY RJ ALEXIOU A REINCKE H SEGALL JD WALTERS B SWOR R GILROY J GOETTING M JACKSON R RICHARDSON D CISEK J RANDALL J SCHECTER S WILKINSON K WALTERS BL ADAMS R CARL E NICHOLS F HESS D BOOP B EARLEY C SMITH DR KAPLAN P JOHNSON C MORROW C FROHMAN E PORTER N FLANIGAN K MORGANSTERN L HOLLAND N STEIN A ALDRICH E OYLER G FAUGHT E MITCHELL V LIU H THOMAS F WENZEL D DAJANI BM PAN JL YAPUNDICH R FUTATSUGI Y GEERLINGS S MOSKOWITZ T NICHOLAS A BROCKINGTON J COLLINS A BAILEY JM TSENG A KOROSHETZ WJ CAN U FELIX A CUDKOWTICZ M BUONANNO F SCHWAMM L ELKIND M KISTLER JP FINKELSTEIN S CHA J MURPHY S BLUMENFELD H LOPEZBRESNAHAN M CAN U GOSLIN K CRAMER S SUWANWELA N HOMER D CARPENTER J WITYK R MICHEL N GRUFFERMAN S LITT B WEISS H GUYOT A PETERSON P TVARDEK L SCHMIDT J DESHPANDE A FREIJ W GANDHI B MINHAS F SHAH J ZAHKA C PENN A SHERMAN J LI YL ELLEKER MG STENERSON P BROOKE H ALJUMAH M ALAYAFY H POKROY R HOPPE B PASCUZZI R FARLOW M RIGHTMYER D BALES M CARESS J PETTIGREW C WAUGH C ROCKICH A FALLIS R TIKHTMAN A STARKMAN S SCHUBERT G DOBKIN B MARTIN N SAVER J HANSON S WEAVER A PORTH K MAGANA R DAVENPORT J TAYLOR F FREKING D HEROS DO SCHNEK E ALTER M RIBEIRO R LLOYD M SCHEINER S PUFF A BOYLE S GUPTA N WHITE K CARNEY S MOULTON M LACAPRA S HASSARD D RIZWAN S SHAH A NEWMARK A GUPTA A CONE D KHAN I COHEN B BOPARI R OCONNELL J HUSSIAN A PATIL K SHOJARI J RIBEIRO R BELL R GZECH D MAZER T GROTHUSEN J REYES P ARASTU J STRASSBURGER T THOMAS C WOLFE R FANG J SCAVINA M WOLFE W ZEIDWERG D CHAVIN J SHACHAR O SANDLER L MCGARREN D JAMIESON DG GONNELLA C BOSLEY TM POLLACK DA ANDREFSKY JC HARIHARAN S CHANG A LAMONTE MP CHAMPELLONE J HOOKER HC FELLUS J SOSA V RAAF S FRIEDMAN M BURCH G ATKINS D FOLEY C BIVINS D ELIAS W NOLAN D SISK M WILSON J LLOYD A STEPHENS G SURRUSCO R LOTHES C HUMPHRIES W PASTEMAK S DONATO M MANETTA E MITCHELL J BRIGGS A RORRER M OFFERMANN P GROVER W BOLTON B LYDEN P LEWIS S RAPP K BRODY M ROTHROCK J JACKSON C HUOTT P KUSHIDA C LISS J ZWEIFER R CAYLOR L PHAN D MAHDAVI Z TOM T NOACK H FORDE G CAMERON D GRIESDALE B MAKIN V BOZEK CB SHEPPARD G MASSEY S ZONTINE D CROWE N GUSTIN K CAPONE P FEASBY TE ROBERTSON C RORICK M WINKELMAN M LISKAY A SCHMIDLEY J COLE M ALJABERI M ANAGNOS A ANDERSON M BAMFORD C FREDERICKSON E GORDON J GROSSER S KORI A KUNTZ A MURAD M NASREDDINE W PETTEE A RIACHI N SCHECHT H STAHL J SORIANO J SUNSHINE J SUAREZ J VANDERSLUIS J ALLANHAM Y RAMAHI A SHUAIB A KADRIBASIC E STEWART B BEAUDRY M BOIVIN D LYONS G DOUGAL RL SIMSARIAN JP MCGARVEY M GRASS D SIGMUND L KURTZKE R EBERLY L LIPPS D FESENMEIER JT VIATER K ALONZO R COOPER W SCOTT J BUSTION P PAPPAS J FRAZER M HALEY EC ALVES W KASSELL NF JOHNSTON KC FORD G SOLENSKI N SHREVE DL WILKINSON SS CLEMENTS S CUCCIA E ELDER L KELLER M LACKEY R MIMMS K PROTZMAN P SPARROW L LIGHTFOOT A LIGHTFOOT AE BOCCHICCHIO BE HALLEY P POLIN A POLIN R HWANG LJ WOLF MC TRUSKOWSKI LL GALBRIETH C JOHNSON R JOHNSON S HILL C WILSON B BARTLEY A FORD G RUMFELT M WINGATE V SMITH M CHILDRESS T POWERS WJ WALKER M FLEISS JL FRANKEL M SIMON RP MARLER J ADAMS HP BROTT TG CHOI S KURTZKE JF TORNER JC PETERS GR ECKERT S BRYAN WJ BOLOGA ML LEGACE D BRENNAN KM
Citation: P. Scott et al., A RANDOMIZED TRIAL OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE STROKE (RANTTAS), Stroke, 27(9), 1996, pp. 1453-1458
SAFETY AND EFFICACY OF 6 MG KG/DAY TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (TESS STUDY)/
Authors: PETERS GR HWANG LJ MUSCH B BROSSE DM ORGOGOZO JM
Citation: Gr. Peters et al., SAFETY AND EFFICACY OF 6 MG KG/DAY TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (TESS STUDY)/, Stroke, 27(1), 1996, pp. 161-161
COMPARISON OF THE PHARMACOKINETICS OF TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS AND STABLE SUBJECTS WITH MILD LIVER-CIRRHOSIS
Authors: PEARSON LK FLEISHAKER JC PETERS GR
Citation: Lk. Pearson et al., COMPARISON OF THE PHARMACOKINETICS OF TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS AND STABLE SUBJECTS WITH MILD LIVER-CIRRHOSIS, European Journal of Clinical Pharmacology, 50(4), 1996, pp. 299-304
GENDER DOES NOT AFFECT THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCEBY PHENOBARBITAL
Authors: FLEISHAKER JC PEARSON LK PETERS GR
Citation: Jc. Fleishaker et al., GENDER DOES NOT AFFECT THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCEBY PHENOBARBITAL, European Journal of Clinical Pharmacology, 50(1-2), 1996, pp. 139-145
BIOTRANSFORMATION OF TIRILAZAD IN HUMAN .2. EFFECT OF KETOCONAZOLE ONTIRILAZAD CLEARANCE AND ORAL BIOAVAILABILITY
Authors: FLEISHAKER JC PEARSON PG WIENKERS LC PEARSON LK PETERS GR
Citation: Jc. Fleishaker et al., BIOTRANSFORMATION OF TIRILAZAD IN HUMAN .2. EFFECT OF KETOCONAZOLE ONTIRILAZAD CLEARANCE AND ORAL BIOAVAILABILITY, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 991-998
EFFECT OF GENDER ON THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCE BYPHENYTOIN
Authors: FLEISHAKER JC PEARSON LK PETERS GR
Citation: Jc. Fleishaker et al., EFFECT OF GENDER ON THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCE BYPHENYTOIN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 39-39
PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTS
Authors: FLEISHAKER JC PETERS GR
Citation: Jc. Fleishaker et Gr. Peters, PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 53-53
CARDIOVASCULAR AND HORMONAL EFFECTS OF PRAMIPEXOLE, A NOVEL DOPAMINE AGONIST
Authors: PETERS GR FRANCOM SF WRIGHT CE
Citation: Gr. Peters et al., CARDIOVASCULAR AND HORMONAL EFFECTS OF PRAMIPEXOLE, A NOVEL DOPAMINE AGONIST, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 76-76
DOPAMINE AGONIST DOSE-ESCALATION IN HEALTHY-VOLUNTEERS - TIME-COURSE OF TOLERANCE DEVELOPMENT TO PRAMIPEXOLE EFFECTS
Authors: PETERS GR FRANCOM SF WRIGHT CE
Citation: Gr. Peters et al., DOPAMINE AGONIST DOSE-ESCALATION IN HEALTHY-VOLUNTEERS - TIME-COURSE OF TOLERANCE DEVELOPMENT TO PRAMIPEXOLE EFFECTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 77-77
INFLUENCE OF PROBENECID (PR) AND CIMETIDINE (C) ON PRAMIPEXOLE (PX) PHARMACOKINETICS
Authors: WRIGHT CE SISSSON TL ICHPURANI AK PETERS GR
Citation: Ce. Wright et al., INFLUENCE OF PROBENECID (PR) AND CIMETIDINE (C) ON PRAMIPEXOLE (PX) PHARMACOKINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 99-99
INFLUENCE OF AGE AND GENDER ON PRAMIPEXOLE (PX) PHARMACOKINETICS
Authors: WRIGHT CE SISSON TL ICHHPURANI AK PETERS GR
Citation: Ce. Wright et al., INFLUENCE OF AGE AND GENDER ON PRAMIPEXOLE (PX) PHARMACOKINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 100-100
EVALUATION OF THE DEVELOPMENT OF ACUTE TOLERANCE TO THE PSYCHOMOTOR EFFECTS OF MIDAZOLAM FOLLOWING INTRAVENOUS INFUSIONS IN HEALTHY-VOLUNTEERS
Authors: FLEISHAKER JC CHAMBERS JH PETERS GR
Citation: Jc. Fleishaker et al., EVALUATION OF THE DEVELOPMENT OF ACUTE TOLERANCE TO THE PSYCHOMOTOR EFFECTS OF MIDAZOLAM FOLLOWING INTRAVENOUS INFUSIONS IN HEALTHY-VOLUNTEERS, Human psychopharmacology, 10(2), 1995, pp. 97-104
FOOD PREFERENCES IN DAILY-LIFE - COGNITIVE, AFFECTIVE AND SOCIAL PREDICTORS
Authors: PETERS GR RAPPOPORT LH HUFFCORZINE L NELSEN C DOWNEY RG
Citation: Gr. Peters et al., FOOD PREFERENCES IN DAILY-LIFE - COGNITIVE, AFFECTIVE AND SOCIAL PREDICTORS, Ecology of food and nutrition, 33(3), 1995, pp. 215-228
Risultati: 1-25 | 26-34